Cellular Context Dictates the Suppression or Augmentation of Triple-Negative Mammary Tumor Metastasis by NLRX1

Margaret A Nagai-Singer1, Mackenzie K Woolls1, Katerina Leedy1

  • 1Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, VA.

Insights

The pattern recognition receptor NLRX1 has opposing roles in breast cancer. It suppresses tumors in host cells but promotes cancer growth and metastasis when expressed in tumor cells.

Area of Science:

  • Immunology
  • Cancer Biology
  • Cell Biology

Background:

  • The pattern recognition receptor NLRX1 has poorly defined roles in cancer.
  • Understanding NLRX1's function is crucial for developing cancer therapies.

Purpose of the Study:

  • To investigate the role of NLRX1 in the 4T1 murine mammary carcinoma model.
  • To elucidate the context-dependent functions of NLRX1 in cancer.

Main Methods:

  • Utilized Nlrx1-/- mice engrafted with 4T1 tumors.
  • Performed in vitro and in vivo gain- and loss-of-function studies.
  • Analyzed tumor growth, metastasis, epithelial-mesenchymal transition, cell death, proliferation, migration, reactive oxygen species, and mitochondrial respiration.

Main Results:

  • NLRX1 acts as a tumor suppressor in host cells, reducing tumor growth and lung metastasis.
  • NLRX1 promotes tumor aggressiveness and metastasis when expressed in 4T1 tumor cells.
  • NLRX1 influences epithelial-mesenchymal transition, cell death, proliferation, migration, ROS levels, and mitochondrial respiration.

Conclusions:

  • NLRX1 exhibits a dichotomous role in the 4T1 mammary carcinoma model.
  • The function of NLRX1 is dictated by its cellular context (host vs. tumor cells).
  • NLRX1 represents a potential therapeutic target with context-specific implications in breast cancer.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.9K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.4K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K